Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Rebecca Miksad

GI Oncology · BMC

View

Dr. Colin Weekes

GI Oncology · MGH

View

Dr. Elizabeth Jaffee

GI Oncology · Johns Hopkins

View

Dr. Laura Vater

GI Oncology · IUSM

View

Dr. Kathleen Cooney

GU Oncology · Duke

View

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Julia Close

General Oncology · UF

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Allison Fitzgerald

General Oncology · Dana-Farber Cancer Institute

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    APDr. Aparna Parikh
    Leading Voice

    Dr. Aparna Parikh

    Medical Oncology · Gastrointestinal Oncology
    Mass General Brigham
    aparna

    Research

    A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors

    2025

    Via Clinical Cancer Research

    Research

    Genomic alterations associated with early-stage disease and early recurrence in patients with colorectal cancer

    2025

    Via The Oncologist

    Research

    Long-term Outcomes of Definitive Chemoradiation With Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of Two Prospective Trials

    2025

    Via International Journal of Radiation Oncology, Biology, Physics

    Research

    A phase II study of ramucirumab and somatostatin analog therapy in patients with advanced neuroendocrine tumors

    2025

    Via The Oncologist

    Research

    Severe Lymphopenia Predicts Poorer Survival in Patients With Rectal Cancer Undergoing Neoadjuvant Chemoradiation

    2025

    Via Cancer Journal

    Research

    Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group

    2025

    Via JCO Precision Oncology

    Research

    Genetic Polymorphisms in MHC Classes I and II Predict Outcomes in Metastatic Colorectal Cancer

    2025

    Via International Journal of Molecular Sciences

    Research

    Authors' Reply to the Letter to the Editor by Kim et al: Are We Asking the Right Question for New Biomarkers

    2025

    Via Journal of the National Comprehensive Cancer Network

    Research

    Qualitative study of patient and caregiver experiences during multimodality treatment for locally advanced rectal cancer

    2025

    Via The Oncologist

    Research

    Personalized Treatment Modalities for Rectal Cancer: Advances in Neoadjuvant Treatment

    2025

    Via Journal of Clinical Medicine

    Research

    A blueprint for creating an early-onset colorectal cancer program based on experiences from 7 clinical centers across the United States and Canada

    2025

    Via The Oncologist

    Research

    Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer

    2025

    Via JCO Precision Oncology

    Research

    Feasibility, Safety, and Efficacy of Aggressive Multimodal Management of Elderly Patients With Pancreatic Ductal Adenocarcinoma

    2024

    Via Annals of Surgery

    Research

    Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies

    2024

    Via Theranostics

    Research

    A standing platform for cancer drug development using ctDNA-based evidence of recurrence

    2024

    Via Nature Reviews Cancer